Showing 30 of 3783 posts
EKF Diagnostics' FY 2025 results show 9.3% adjusted EBITDA growth, thriving margins, strong cash flow & a clear five-year strategic blueprint. Analysis inside.
JoshuaMarch 24, 2026
BioPharma Credit's strong 2025: Higher net income per share, fully covered dividends, and a cash war chest for new deals.
JoshuaMarch 24, 2026
Distil warns of revenue shortfall due to trade destocking, despite strong consumer demand. Immediate funding need and US launch delay add pressure. Analysis inside.
JoshuaMarch 24, 2026
Michelmersh Brick's 2025 results: profit squeeze, CFO steps down, but dividend steady amid market challenges.
JoshuaMarch 24, 2026
Flowtech Fluidpower reports 30.5% underlying EBITDA growth, enters new 'grow and build' phase after strong second-half turnaround.
JoshuaMarch 24, 2026
Fevertree’s FY25 results show steady brand revenue growth and strong diversification, but profitability dipped due to US transition costs and an environmental levy provision.
JoshuaMarch 24, 2026
Record Hallam Land plot sales and strategic refocus anchor Henry Boot's resilient 2025 results, as higher net debt and homebuilding losses pose challenges.
JoshuaMarch 24, 2026
Personal Group beats FY25 expectations with 22% EBITDA growth and a 41% dividend hike, backed by a 90% recurring revenue engine.
JoshuaMarch 24, 2026
Xaar's 2025 results show adjusted profit back in black, driven by 22% printhead growth and a commercial breakthrough in jewellery wax 3D printing.
JoshuaMarch 24, 2026
Tandem Group's FY25: profits beat forecasts, dividend reinstated at 3.0p, and net debt more than halved to £1.9m.
JoshuaMarch 23, 2026
Blackbird's 2025 results show cost discipline, a profitable core division, and early growth for its elevate.io video editor with 138k users and a 1.1% paid conversion rate.
JoshuaMarch 23, 2026
PGPE Ltd's 2025 results show an 8.7% NAV decline but a 5.3% share price rise. With a 19.6% discount, the Board is reviewing strategic options to boost liquidity and narrow the gap.
JoshuaMarch 23, 2026
Applied Nutrition's H1 FY26 interim results show 56.5% revenue growth to £74.5m, with stable margins and £140m full-year guidance.
JoshuaMarch 23, 2026
Built Cybernetics returns to profit in 2025 as its pivot to software pays off, with proprietary recurring revenue surging 69% to £751k.
JoshuaMarch 23, 2026
DF Capital smashed 2025 targets, grew its loan book 27%, and launched its new DFRNT asset finance arm to accelerate future growth.
JoshuaMarch 23, 2026
Thungela posts a 2025 loss on non-cash impairments but operations beat guidance, costs were controlled, and a R2 final dividend declared. Resilient performance.
JoshuaMarch 23, 2026
Amid headwinds, RTC Group holds earnings, boosts cash, and hikes dividend, backed by rail, energy, and water sectors.
JoshuaMarch 23, 2026
Progress on flagship MSC and Cargill marine fuel trials. £4m cash provides runway for 2026 commercialisation push.
JoshuaMarch 23, 2026
Caspian Sunrise diversifies into manganese & gold with $45M deal: $25M at 127% premium now, $20M later if gold reserves certified.
JoshuaMarch 23, 2026
Empire Metals' transformational 2025 delivered a 2.2Bt maiden titanium resource, 99.25% high-purity product, and a strong £8.4m cash position to fund a busy 2026.
JoshuaMarch 23, 2026
Profits surge 193% to $67.5m as gold price rallies. Quarterly dividend declared. Bilboes development funded for growth.
JoshuaMarch 23, 2026
Pennant's 2025 reset saw revenue fall, but a fortified £23.3m order book and record software ARR signal a sharper, software-led future. 2026 execution is key.
JoshuaMarch 23, 2026
ME Group reports record £78.2m profit, raises dividend 9.5%, and launches an £18m share buyback, driven by strong growth in its Wash.ME laundry division.
JoshuaMarch 23, 2026
Gfinity halves losses & triples cash as AI divisions gain traction. Media profits, ad-tech commercialises & sovereign AI launches.
JoshuaMarch 23, 2026
Aterian's JV with Wogen boosts Rwanda tantalum trading: faster growth, better funding, and traceable supply amid record prices. A strategic step toward profitability.
JoshuaMarch 23, 2026
PPHC instantly boosts earnings by acquiring economics consultancy WPI Strategy, deepening its UK economics-led advisory firepower within its Pagefield group.
JoshuaMarch 23, 2026
Focusrite's trading update shows resilient margins and reduced debt, with revenue slightly below forecasts but profitability on track. A steady performance in volatile markets.
JoshuaMarch 19, 2026
BSF Enterprise's 3D Bio-Tissues signs a 5-year supply deal with SeaWith. Its City-Mix additive aims to cut cultivated meat growth media costs by ~30%, a strategic commercial win for scaling production.
JoshuaMarch 19, 2026
JPMorgan Global Growth & Income's H1 2025 lags short-term but beats benchmarks over 5 years. Targets 23p dividend, tight discount, and adjusted portfolio.
JoshuaMarch 19, 2026
NAV fell to 35.9p per share, but capital returns of 4.0p have begun. The future value hinges on execution at key assets Dacian Petroleum and Castle View.
JoshuaMarch 19, 2026